Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing four strategically located R&D centers in New Jersey (USA), California (USA), Toronto (Canada), and Suzhou (China), we are powered by a skilled team of around 300 professionals.
As a leader in both conventional and enabling formulation technologies, including amorphous solid dispersion, we take pride in our cGMP facilities, strictly adhering to the rigorous standards set by the FDA, EMA, and NMPA. Our integrated service encompasses the entire new drug development journey, from developability assessment and solid form screening to pre-formulation, formulation development, and CTM and commercial manufacturing.
Introducing our pioneering Mol2Med program, designed to expedite small molecule lead compounds or preclinical candidates into Phase I and beyond, with unparalleled efficiency and precision. This 3-step First-Time-Right approach begins at the lead optimization/PCC stage:
Step 1: Developability Assessment to guide API form selection and formulation design.
Step 2: Solid form screening/selection and Preformulation.
Step 3: Formulation development and CTM manufacturing, including packaging, labeling, and shipping to the clinical site.
This innovative approach guarantees a robust API form and a scalable manufacturing process, culminating in a First-Time-Right formulation for Phase I. Streamlining the transition to future clinical studies upon Phase I success, our First-Time-Right approach sets the foundation for optimized drug development and success beyond.
Company Details
- Employees
- 75
- Founded
- -
- Address
- 3000 Eastpark Blvd,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.crystalpharmatech.com
- Keywords
- salt screening, polymorph screening, cocrystal screening, API characterization, API process optimization, API crystallization, chiral resolution, preformulation, amorphous solid dispersion, formulation characterization, crystallization development and optimization, Formulation, GMP Manufacturing, Formulation Development, Clinical and Commercial Manufacturing.
- HQ
- Cranbury, New Jersey
- Competitors
- BIOVECTRA, Crystal Bio, Life Sciences Nova Scotia, J-STAR Research, Inc., Vertex Pharmaceuticals, Crystal Formulation Services, a member of Crystal Pharmatech, Crystal Bio Solutions, a member of Crystal Pharmatech, Solid State Pharma, Candoo Pharmatech Company Inc., Porton Pharma Solutions Ltd..
Crystal Pharmatech Questions
Crystal Pharmatech's website is http://www.crystalpharmatech.com
Crystal Pharmatech's LinkedIn profile is https://www.linkedin.com/company/crystal-pharmatech
Crystal Pharmatech has
75 employees.
View email and phone details for 75
employees at Crystal Pharmatech.
Crystal Pharmatech's industry is
Pharmaceutical Manufacturing
Crystal Pharmatech's top competitors are
Biovectra,
Crystal Bio,
Life Sciences Nova Scotia,
J-Star Research, Inc.,
Vertex Pharmaceuticals,
Crystal Formulation Services, A Member Of Crystal Pharmatech,
Crystal Bio Solutions, A Member Of Crystal Pharmatech,
Solid State Pharma,
Candoo Pharmatech Company Inc.,
Porton Pharma Solutions Ltd..
Crystal Pharmatech's categories are Pharmaceutical Manufacturing
Crystal Pharmatech's founding year is 2010
